Arthur J. Gallagher & Co. (NYSE: AJG) disclosed that its Chief Human Resources Officer, Susan E. Pietrucha, sold 15,020 shares of common stock on November 9, 2026, generating approximately $4,240,161 in proceeds. The shares were sold at an average weighted price of $282.301, with individual transaction prices spanning from $282.08 to $282.575.
The disposition was preceded by the exercise of non-qualified stock options covering an identical number of shares, 15,020, on the same day. Those options carried an exercise price of $86.17 per share, amounting to roughly $1,294,273. The options were part of a grant that vests in one-third increments on the third, fourth, and fifth anniversaries of the grant date.
Following these transactions, Ms. Pietrucha directly holds 16,791.2383 shares of Arthur J. Gallagher common stock. She also holds 367.312 shares indirectly through a Gallagher 401(k) plan account.
Her remaining derivative holdings include various non-qualified stock options with exercise prices ranging from $127.9 to $337.74. In addition, she holds phantom stock representing 101,300.299 shares under the company’s Age 62 Plan and notional stock units representing 15,324.048 shares, which are payable in July 2026 and following her separation from service. The report details the exercise and subsequent sale of stock options expiring in March 2027.
Arthur J. Gallagher & Co. is valued at $71.95 billion and trades at a price-to-earnings ratio of 43.2. According to InvestingPro analysis, the stock appears undervalued at current levels and ranks among the platform’s most undervalued stocks. Subscribers gain access to over 10 additional ProTips for AJG.
In other recent developments, the company reported third-quarter 2026 earnings with adjusted earnings per share of $3.00, slightly exceeding the forecast of $2.99. However, revenue of $3.92 billion fell short of the expected $3.98 billion. Despite the revenue miss, the company saw 25% growth in net earnings and adjusted EBITDAC.
Analyst reactions were mixed. Goldman Sachs reiterated its Buy rating on Arthur J. Gallagher, maintaining a price target of $296 due to in-line results. Keefe, Bruyette & Woods raised its price target for the company from $242 to $275, citing a positive outlook on adjusted EBITDAC margins in the Brokerage segment. Meanwhile, BMO Capital downgraded Arthur J. Gallagher’s stock to Market Perform from Outperform, despite raising the price target to $295, as it decided to take profits. In contrast, Marsh received an upgrade from BMO Capital to Outperform, with a focus on the large-employer market. These developments highlight the dynamic shifts in the insurance brokerage sector.